T2 1847-1136SRecalls & reported problems
Stryker GmbH · Reconstruction Nail R2.0, Ti, RIGHT · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 07613153316961), received between Jul 23, 2018 and Aug 23, 2022 — classified as 3 injuries.
The most frequently reported specific device problem is “Break” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Break3
- Fracture1
Patient problems
- Nonunion/Delayed-union Bone Fracture2
- Failure of Implant1
- Implant Pain1
- No Code Available1
- Sepsis1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryAug 23, 2022Break; Fracture; Break; Fracture
IT WAS REPORTED BY THE PATIENT THAT: "ON (B)(6) 2021 I SUFFERED A FRACTURE OF THE FEMUR IN A SKIING ACCIDENT. THIS WAS SURGICALLY STRAIGHTENED AT THE HOSPITAL IN LIENZ (AUSTRIA) AND THE FRACTURE WAS TREATED WITH A STRYKER NAILING SYSTEM (RECON 11/360). AFTER A LONG RECOVERY (HOSPITAL, REHAB AND PHYSIOTHERAPY ETC.) THE ABOVE MENTIONED INTRAMEDULLARY NAIL BROKE ON (B)(6) 2022. I FELT VERY STRONG PAIN IN THE RIGHT THIGH AND HIP. THE FRACTURE OF THE INTRAMEDULLARY NAIL WAS DIAGNOSED AT THE HOSPITAL AND IT WAS REMOVED DURING ANOTHER SURGERY ON (B)(6) 2022 AND REPLACED BY A NEW NAIL SYSTEM. THIS WAS FOLLOWED BY ANOTHER HOSPITAL STAY AND A NEW REHA IN BAD TABARZ IS STILL PENDING. MY NEW OPERATION CAUSED VERY SEVERE PAIN, WHICH CONTINUES TO THIS DAY. ACCORDING TO THE DOCTORS, THE SITUATION WILL NOT CHANGE FOR THE TIME BEING."
Patient problems: Failure of Implant; Implant Pain; Nonunion/Delayed-union Bone Fracture
MAUDE report 15280304 ↗InjuryJul 23, 2018Break
THE MANUFACTURER BECAME AWARE OF A POST MARKET CLINICAL FOLLOW-UP (PMCF) FROM (B)(6) HOSPITAL (B)(6). THE TITLE OF THIS REPORT IS ¿ANALYSIS OF THE T2 RECON NAIL USED WITH THE ANTEGRADE LOCKING MODE¿ WHICH WAS RELEASED IN JUNE 2018 AND IS ASSOCIATED WITH THE T2 RECON NAILING SYSTEM. WITHIN THAT REPORT, POSTOPERATIVE COMPLICATIONS/ ADVERSE EVENTS WERE REPORTED, WHICH OCCURRED BETWEEN JANUARY 2014 AND NOVEMBER 2017. BASED ON THE AVAILABLE DEVICE AND PATIENT INFORMATION AND A REVIEW OF COMPLAINT HANDLING DATABASE IT WAS REVEALED THAT THE EVENTS HAVE NOT BEEN REPORTED BY THE HOSPITAL OR BY THE AUTHOR OF THE REPORT, THEREFORE 15 COMPLAINTS WERE INITIATED RETROSPECTIVELY FOR DIFFERENT ADVERSE EVENTS MENTIONED IN THE JOURNAL. THIS PRODUCT INQUIRY ADDRESSES SEPTIC NONUNION DISCOVERED FROM THE EVENT OF CASE ID (B)(6). ONE OUT OF 1 CASE. THE PMCFR STATES: ¿IN THE SECOND CASE (CASE (B)(6)) IT WAS A TRANSVERSE FRACTURE (32-A) IN A HEAVY (B)(6) YEARS LADY. SHE IS 1,63 M IN HEIGHT FOR A WEIGHT OF (B)(6) KG (BMI OF (B)(6)). THE BREAKAGE OF ALL THREE LOCKING SCREWS WAS OBSERVED. IN FACT A SEPTIC NONUNION WAS OBSERVED AND A REVISION SURGERY WAS PERFORMED 142 DAYS AFTER THE INITIAL SURGERY. ALL THE B
Patient problems: Nonunion/Delayed-union Bone Fracture; Sepsis
MAUDE report 7710742 ↗InjuryJul 23, 2018Break
THE MANUFACTURER BECAME AWARE OF A POST MARKET CLINICAL FOLLOW-UP (PMCF) FROM (B)(6). THE TITLE OF THIS REPORT IS ¿ANALYSIS OF THE T2 RECON NAIL USED WITH THE ANTEGRADE LOCKING MODE¿ WHICH WAS RELEASED IN JUNE 2018 AND IS ASSOCIATED WITH THE T2 RECON NAILING SYSTEM. WITHIN THAT REPORT, POSTOPERATIVE COMPLICATIONS/ ADVERSE EVENTS WERE REPORTED, WHICH OCCURRED BETWEEN JANUARY 2014 AND NOVEMBER 2017. BASED ON THE AVAILABLE DEVICE AND PATIENT INFORMATION AND A REVIEW OF COMPLAINT HANDLING DATABASE IT WAS REVEALED THAT THE EVENTS HAVE NOT BEEN REPORTED BY THE HOSPITAL OR BY THE AUTHOR OF THE REPORT, THEREFORE 15 COMPLAINTS WERE INITIATED RETROSPECTIVELY FOR DIFFERENT ADVERSE EVENTS MENTIONED IN THE JOURNAL. THIS PRODUCT INQUIRY ADDRESSES IMPLANT BREAKAGE. TWO (CASE ID 62) OUT OF 3 CASES. THE PMCFR STATES: ¿IN 3 CASES (CASE 20,62 AND 71) BREAKAGE OF THE MATERIAL OCCURRED. THE BREAKAGE WAS SITUATED ON THE LOCKING SCREWS AND NEVER ON THE NAIL ITSELF. IN THE SECOND CASE (CASE 62) IT WAS A TRANSVERSE FRACTURE (32-A) IN A HEAVY 70 YEARS LADY. SHE IS 1,63M IN HEIGHT FOR A WEIGHT OF (B)(6). THE BREAKAGE OF ALL THREE LOCKING SCREWS WAS OBSERVED. IN FACT A SEPTIC NONUNION WAS OBSERVED AND A REVIS
Patient problems: No Code Available
MAUDE report 7710515 ↗
Other ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES devices
- NA 03.033.001Synthes GmbH · ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES265 reports
- GAMMA 3125-1180SStryker GmbH · ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES249 reports
- NA 03.037.026Synthes GmbH · ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES225 reports
- PRECICE® Intramedullary Limb Lengthening System LSC5-075Nuvasive Specialized Orthopedics, Inc. · Rod, Fixation, Intramedullary And Accessories4 recalls2 reports
- PRECICE® Intramedullary Limb Lengthening System LSC5-045Nuvasive Specialized Orthopedics, Inc. · Rod, Fixation, Intramedullary And Accessories4 recalls1 report
- PRECICE® Intramedullary Limb Lengthening System LSC5-050Nuvasive Specialized Orthopedics, Inc. · Rod, Fixation, Intramedullary And Accessories4 recalls1 report
- TRIGEN 71674067Smith & Nephew, Inc. · ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES201 reports
- PRECICE Intramedullary Limb Lengthening System LSB5-040Nuvasive Specialized Orthopedics, Inc. · Rod, Fixation, Intramedullary And Accessories4 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page